| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 72 | 67 | 71 | 77 | 0 | 110 | 88 | 154 | 103 | 111 |
| Total Income - EUR | 72 | 67 | 71 | 77 | 0 | 110 | 88 | 154 | 103 | 111 |
| Total Expenses - EUR | 402 | 249 | 190 | 176 | 162 | 209 | 178 | 181 | 189 | 156 |
| Gross Profit/Loss - EUR | -330 | -183 | -120 | -99 | -162 | -99 | -90 | -27 | -86 | -45 |
| Net Profit/Loss - EUR | -333 | -185 | -122 | -102 | -162 | -102 | -93 | -32 | -86 | -45 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Egeo Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.312 | 29.013 | 28.522 | 27.998 | 27.456 | 26.936 | 26.338 | 26.420 | 26.340 | 26.193 |
| Current Assets | 88 | 58 | 75 | 187 | 74 | 44 | 88 | 160 | 276 | 229 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 88 | 0 | 0 | 0 |
| Cash | 88 | 58 | 75 | 187 | 74 | 44 | 0 | 160 | 276 | 229 |
| Shareholders Funds | -4.036 | -4.179 | -4.231 | -4.255 | -4.334 | -4.354 | -4.351 | -4.396 | -4.468 | -4.488 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 33.435 | 33.250 | 32.828 | 32.440 | 31.865 | 31.334 | 30.777 | 30.976 | 31.084 | 30.910 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4110 - 4110" | |||||||||
| CAEN Financial Year |
4110
|
|||||||||
Comments - Egeo Med S.r.l.